Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on Salvianolic Acid A PK in Healthy Subjects
NCT03791463Phase 1Unknown
- Sponsor
- Peking University First Hospital
- Start
- Dec 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of salvianolic acid a in cardiovascular disease (CVD), sponsored by Peking University First Hospital. Primary endpoint: Pharmacokinetics of salvianolic acid A at 24 hours. Status: unknown.
02
Drugs
salvianolic acid a
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03791463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791463.